Table 7 Pathway analysis of spleen subcutaneous tissue
Term name | Description | FDR value |
|---|---|---|
hsa05200 | Pathways in cancer | 2.04E−23 |
hsa04151 | PI3K-Akt signaling pathway | 2.87E−23 |
hsa05418 | Fluid shear stress and atherosclerosis | 3.1E−21 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 4.72E−17 |
hsa04510 | Focal adhesion | 1.25E−16 |
hsa04010 | MAPK signaling pathway | 3.21E−16 |
hsa04068 | FoxO signaling pathway | 6.03E−16 |
hsa04015 | Rap1 signaling pathway | 1.03E−15 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.99E−15 |
hsa04668 | TNF signaling pathway | 2.64E−15 |
hsa05215 | Prostate cancer | 9.63E−15 |
hsa05145 | Toxoplasmosis | 4.8E−14 |
hsa04066 | HIF-1 signaling pathway | 5.38E−14 |
hsa04211 | Longevity regulating pathway | 6.4E−11 |
hsa04014 | Ras signaling pathway | 2.14E−10 |
hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.38E−10 |
hsa04910 | Insulin signaling pathway | 8.87E−8 |